Journal of Substance Abuse Treatment
Volume 26, Issue 4 , Pages 261-267 , June 2004

Residential treatment for smokeless tobacco use: A case series

  • Jon O Ebbert, MD, MSc

      Affiliations

    • Corresponding Author InformationCorresponding author. Nicotine Dependence Center, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Tel.: +1-507-266-1944; fax: +1-507-266-7900
    • Nicotine Dependence Center, Mayo Clinic, 200 First Street, SW, Rochester, MN, USA
    • Division of Community Internal Medicine, Mayo Clinic, 200 First Street, SW, Rochester, MN, USA
    • ,
  • Lowell C Dale, MD

      Affiliations

    • Nicotine Dependence Center, Mayo Clinic, 200 First Street, SW, Rochester, MN, USA
    • Division of Community Internal Medicine, Mayo Clinic, 200 First Street, SW, Rochester, MN, USA
    • ,
  • Kristin S Vickers, PhD

      Affiliations

    • Section of Patient Education, Mayo Clinic, 200 First Street, SW, Rochester, MN, USA
    • Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street, SW, Rochester, MN, USA
    • ,
  • Thomas R Gauvin, MA

      Affiliations

    • Nicotine Dependence Center, Mayo Clinic, 200 First Street, SW, Rochester, MN, USA
    • ,
  • Nadene E Bunge, MA

      Affiliations

    • Department of Dental Specialties, Mayo Clinic, 200 First Street, SW, Rochester, MN, USA
    • ,
  • Richard D Hurt, MD

      Affiliations

    • Nicotine Dependence Center, Mayo Clinic, 200 First Street, SW, Rochester, MN, USA

Received 6 September 2003 ,Revised 6 January 2004 ,Accepted 27 January 2004.

References 

  1. Andrews JA, Severson HH, Lichtenstein E, Gordon JS, Barckley MF. Evaluation of a dental office tobacco cessation program: effects on smokeless tobacco use. Annals of Behavioral Medicine. 1999;21:48–53
  2. Bandura A. Social learning theory. Englewood Cliffs, NJ: Prentice Hall; 1977;
  3. Bandura A. Self-efficacy: The exercise of control. New York: W.H. Freeman; 1997;
  4. Benowitz NL. Systemic absorption and effects of nicotine from smokeless tobacco. Advances in Dental Research. 1997;11:336–341
  5. Benowitz NL, Jacob P, Yu L. Daily use of smokeless tobacco: systemic effects. Annals of Internal Medicine. 1989;111:112–116
  6. Benowitz NL, Porchet H, Sheiner L, Jacob P. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clinical Pharmacology & Therapeutics. 1988;44:23–28
  7. Benowitz NL, Zevin S, Jacob P. Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine. Journal of Pharmacology & Experimental Therapeutics. 1998;287:958–962
  8. Boyle RG. Smokeless tobacco cessation with nicotine replacement: a randomized clinical trial. Dissertation Abstracts International. 1992;54:825
  9. Dale LC, Ebbert JO, Schroeder DR, Croghan IT, Rasmussen DF, Trautman JA, et al. Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study. Nicotine & Tobacco Research. 2002;4:267–274
  10. Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation. JAMA. 1995;274:1353–1358
  11. Ebbert JO, Dale LC, Nirelli LM, Schroeder DR, Moyer TP, Hurt RD. Cotinine as a marker for nicotine exposure in spit tobacco users. Addictive Behaviors. 2004;29:349–355
  12. Ebbert JO, Rowland LC, Montori VM, Vickers KS, Erwin PJ, Dale LC. Treatments for spit tobacco use: a quantitative systematic review. Addiction. 2003;98:569–583
  13. Fredrickson PA, Hurt RD, Lee GM, Wingender L, Croghan IT, Lauger G, et al. High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels. Psychopharmacology. 1995;122:215–222
  14. Glover E, Glover P, Sullivan C, Cerullo C, Hobbs G. A comparison of sustained-release bupropion and placebo for smokeless tobacco cessation. American Journal of Health Behavior. 2002;26:386–393
  15. Hatsukami D, Jensen J, Allen S, Grillo M, Bliss R. Effects of behavioral and pharmacological treatment on smokeless tobacco users. Journal of Consulting & Clinical Psychology. 1996;64:153–161
  16. Hatsukami DK, Grillo M, Boyle R, Allen S, Jensen J, Bliss R, et al. Treatment of spit tobacco users with transdermal nicotine system and mint snuff. Journal of Consulting and Clinical Psychology. 2000;68:241–249
  17. Hatsukami DK, Severson HH. Oral spit tobacco: addiction, prevention and treatment. Nicotine & Tobacco Research. 1999;1:21–44
  18. Hays JT, Ebbert JO. Bupropion for the treatment of tobacco dependence: guidelines for balancing risks and benefits. CNS Drugs. 2003;17:71–83
  19. Hays JT, Wolter TD, Eberman KM, Croghan IT, Offord KP, Hurt RD. Residential (inpatient) treatment compared with outpatient treatment for nicotine dependence. Mayo Clinic Proceedings. 2001;76:124–133
  20. Hoffman EH, Blackburn C, Cullari S. Brief residential treatment for nicotine addiction: a five-year follow-up study. Psychology Report. 2001;89:99–105
  21. Howard-Pitney B, Killen JD, Fortmann SP. Quitting chew: results from a randomized trail using nicotine patches. Experimental and Clinical Psychopharmacology. 1999;7:362–371
  22. Hughes JR, Lesmes GR, Hatsukami DK, Richmond RL, Lichtenstein E, Jorenby DE, et al. Are higher doses of nicotine replacement more effective for smoking cessation?. Nicotine & Tobacco Research. 1999;1:169–174
  23. Hurt RD, Dale LC, Offord KP, Bruce BK, McClain FL, Eberman KM. Inpatient treatment of severe nicotine dependence. Mayo Clinic Proceedings. 1992;67:823–828
  24. Jacob P, Yu L, Shulgin AT, Benowitz NL. Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes. American Journal of Public Health. 1999;89:731–736
  25. Jorenby DE, Smith SS, Fiore MC, Hurt RD, Offord KP, Croghan IT, et al. Varying nicotine patch dose and type of smoking cessation counseling. JAMA. 1995;274:1347–1352
  26. Marlatt GA, Gordon JR. Relapse prevention: maintenance strategies in the treatment of addictive behaviors. New York: Guilford Press; 1985;
  27. Masouredis CM, Hilton JF, Grady D, Gee L, Chesney M, Hengl L, et al. A spit tobacco cessation intervention for college athletes: three-month results. Advances in Dental Research. 1997;11:354–359
  28. Moyer TP, Charlson JR, Enger RJ, Dale LC, Ebbert JO, Schroeder DR, et al. Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. Clinical Chemistry. 2002;48:1460–1471
  29. Mulligan S, Masterson J, Devane J, Kelly J. Clinical and pharmacokinetic properties of a transdermal nicotine patch. Clinical Pharmacology and Therapeutics. 1990;47:331–337
  30. Paoletti P, Fornai E, Maggiorelli F, Puntoni R, Viegi G, Carrozzi L, et al. Importance of baseline cotinine plasma values in smoking cessation: results from a double-blind study with nicotine patch. European Respiratory Journal. 1996;9:643–651
  31. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. Journal of Consulting and Clinical Psychology. 1983;51:390–395
  32. Severson HH, Andrews JA, Lichtenstein E, Gordon JS, Barckley MF. Using the hygiene visit to deliver a tobacco cessation program: results of a randomized clinical trial. Journal of the American Dental Association. 1998;129:993–999
  33. Silagy C, Mant D, Fowler G, Lancaster T. Nicotine replacement therapy for smoking cessation. [Systematic Review] Cochrane Tobacco Addiction. Cochrane Database of Systematic Reviews. 2001;2
  34. Substance Abuse and Mental Health Services Administration . Results from the 2001 National Household Survey on Drug Abuse: Volume I. Summary of National Findings. (NHSDA Series H-17, DHHS Publication No. SMA 02–3758). Rockville, MD: Office of Applied Studies; 2002;
  35. Tonnesen P, Paoletti P, Gustavsson G, Russell MA, Saracci R, Gulsvik A, et al. Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. European Respiratory Journal. 1999;13:231–232
  36. U.S. Department of Health and Human Services . 10th Report on Carcinogens. Public Health Service, National Toxicology Program. Retrieved January 12, 2003 Available: http://ehp.niehs.nih.gov/roc/toc10.html 2002;

PII: S0740-5472(04)00012-1

doi: 10.1016/j.jsat.2004.01.008

Journal of Substance Abuse Treatment
Volume 26, Issue 4 , Pages 261-267 , June 2004

Article Tools

* Image Usage & Resolution